Pancreatic cancer epidemiology and demographics: Difference between revisions
No edit summary |
No edit summary |
||
| Line 1: | Line 1: | ||
__NOTOC__ | |||
{{Pancreatic cancer}} | {{Pancreatic cancer}} | ||
{{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | {{CMG}}; '''Associate Editor-In-Chief:''' {{CZ}} | ||
== | ==Epidemiology and Demographics== | ||
'''Pancreatic cancer''' is a [[cancer|malignant tumour]] within the [[pancreas|pancreatic gland]]. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more than 60,000 in Europe. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive five years after diagnosis, and complete [[remission (medicine)|remission]] still extremely rare.<ref name=Ghaneh>{{cite journal |author=Ghaneh P, Costello E, Neoptolemos JP |title=Biology and management of pancreatic cancer |journal=Gut |volume=56 |issue=8 |pages=1134-52 |year=2007 |pmid=17625148 |doi=10.1136/gut.2006.103333}}</ref> | '''Pancreatic cancer''' is a [[cancer|malignant tumour]] within the [[pancreas|pancreatic gland]]. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more than 60,000 in Europe. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive five years after diagnosis, and complete [[remission (medicine)|remission]] still extremely rare.<ref name=Ghaneh>{{cite journal |author=Ghaneh P, Costello E, Neoptolemos JP |title=Biology and management of pancreatic cancer |journal=Gut |volume=56 |issue=8 |pages=1134-52 |year=2007 |pmid=17625148 |doi=10.1136/gut.2006.103333}}</ref> | ||
About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | About 95 percent of pancreatic tumors are [[adenocarcinoma]]s ({{ICDO|8140|3}}). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic [[neuroendocrine tumor]]s (such as [[insulinoma]]s, {{ICDO|8150|1}}, {{ICDO|8150|3}}). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.<ref name=Ghaneh/> | ||
==Awareness== | ===Awareness=== | ||
*November is Pancreatic Cancer Awareness ribbon|Awareness Month | *November is Pancreatic Cancer Awareness ribbon|Awareness Month | ||
*Purple is the traditional color chosen to represent pancreatic cancer awareness. | *Purple is the traditional color chosen to represent pancreatic cancer awareness. | ||
| Line 25: | Line 26: | ||
[[Category:Oncology]] | [[Category:Oncology]] | ||
[[Category:Mature chapter]] | [[Category:Mature chapter]] | ||
[[Category:Primary care]] | |||
[[Category:Needs overview]] | |||
Revision as of 04:03, 9 May 2013
|
Pancreatic cancer Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Pancreatic cancer epidemiology and demographics On the Web |
|
American Roentgen Ray Society Images of Pancreatic cancer epidemiology and demographics |
|
Risk calculators and risk factors for Pancreatic cancer epidemiology and demographics |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor-In-Chief: Cafer Zorkun, M.D., Ph.D. [2]
Epidemiology and Demographics
Pancreatic cancer is a malignant tumour within the pancreatic gland. Each year about 33,000 individuals in the United States are diagnosed with this condition, and more than 60,000 in Europe. Depending on the extent of the tumor at the time of diagnosis, the prognosis is generally regarded as poor, with few victims still alive five years after diagnosis, and complete remission still extremely rare.[1]
About 95 percent of pancreatic tumors are adenocarcinomas (Template:ICDO). The remaining 5 percent include other tumors of the exocrine pancreas (e.g. serous cystadenomas), acinar cell cancers, and pancreatic neuroendocrine tumors (such as insulinomas, Template:ICDO, Template:ICDO). These tumors have a completely different diagnostic and therapeutic profile, and generally a more favorable prognosis.[1]
Awareness
- November is Pancreatic Cancer Awareness ribbon|Awareness Month
- Purple is the traditional color chosen to represent pancreatic cancer awareness.
- The National Cancer Institute’s cancer research budget was $4.824 billion in 2004, an estimated $52.7 million of which was devoted to pancreatic cancer.[2]
- Research spending per pancreatic cancer patient is $1145, the lowest of any leading cancer.[3]
- The Pancreatic Cancer Action Network (PanCAN) was created as an advocacy group for pancreatic cancer.
- The national charity Pancreatic Cancer UK works to raise awareness in the UK
References
- ↑ 1.0 1.1 Ghaneh P, Costello E, Neoptolemos JP (2007). "Biology and management of pancreatic cancer". Gut. 56 (8): 1134–52. doi:10.1136/gut.2006.103333. PMID 17625148.
- ↑ http://pancan.org/About/pancreaticCancerStats.html
- ↑ http://pancan.org/About/pancreaticCancerStats.html